Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Phreesia, Inc. (PHR) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Phreesia, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1412408.
Total stock buying since 2019: $0.
Total stock sales since 2019: $395,710,356.
Total stock option exercises since 2019: $5,597,798.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 515,497 | $14,757,625 | 126,993 | $780,724 |
| 2024 | 0 | $0 | 478,315 | $11,344,527 | 85,489 | $299,500 |
| 2023 | 0 | $0 | 137,692 | $4,137,863 | 124,783 | $418,691 |
| 2022 | 0 | $0 | 107,326 | $3,004,730 | 282,076 | $952,938 |
| 2021 | 0 | $0 | 751,821 | $48,912,622 | 617,184 | $1,846,306 |
| 2020 | 0 | $0 | 695,484 | $23,401,077 | 775,714 | $1,254,638 |
| 2019 | 0 | $0 | 12,800,764 | $290,151,912 | 54,224 | $45,001 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-07-30 | Indig Chaim (Chief Executive Officer) | Sale | 102 | 70.00 | 7,140 |
| 2021-07-30 | Indig Chaim (Chief Executive Officer) | Option Ex | 102 | 4.71 | 480 |
| 2021-07-29 | Weintraub Michael | Sale | 1,754 | 70.02 | 122,820 |
| 2021-07-29 | Weintraub Michael | Option Ex | 1,754 | 2.03 | 3,560 |
| 2021-07-29 | Indig Chaim (Chief Executive Officer) | Sale | 6,779 | 70.03 | 474,726 |
| 2021-07-29 | Indig Chaim (Chief Executive Officer) | Option Ex | 6,779 | 3.37 | 22,845 |
| 2021-07-21 | Weintraub Michael | Sale | 2,500 | 65.15 | 162,867 |
| 2021-07-21 | Weintraub Michael | Option Ex | 2,500 | 2.03 | 5,074 |
| 2021-07-20 | Weintraub Michael | Sale | 7,500 | 65.08 | 488,137 |
| 2021-07-20 | Weintraub Michael | Option Ex | 7,500 | 2.03 | 15,224 |
| 2021-07-16 | Weintraub Michael | Sale | 20,000 | 63.88 | 1,277,700 |
| 2021-07-16 | Weintraub Michael | Option Ex | 20,000 | 2.03 | 40,599 |
| 2021-07-08 | Munson Gillian | Sale | 3,055 | 63.45 | 193,855 |
| 2021-06-24 | Cahill Edward L | Sale | 5,000 | 60.03 | 300,150 |
| 2021-05-12 | Munson Gillian | Sale | 1,777 | 44.75 | 79,520 |
| 2021-05-04 | Linetsky David (SVP, Life Sciences) | Option Ex | 45,510 | 1.44 | 65,306 |
| 2021-04-30 | Vanduyn Amy Beth (SVP, Human Resources) | Option Ex | 5,688 | 8.03 | 45,674 |
| 2021-04-09 | Davidoff Michael J. (See Remarks) | Sale | 2,134 | 50.96 | 108,746 |
| 2021-04-09 | Davidoff Michael J. (See Remarks) | Option Ex | 2,134 | 4.71 | 10,051 |
| 2021-04-01 | Cahill Edward L | Sale | 15,000 | 54.98 | 824,760 |
| 2021-03-16 | Linetsky David (SVP, Life Sciences) | Sale | 1,578 | 60.15 | 94,911 |
| 2021-03-15 | Linetsky David (SVP, Life Sciences) | Sale | 48,482 | 61.38 | 2,975,631 |
| 2021-02-19 | Altier Thomas (Chief Financial Officer) | Sale | 904 | 73.03 | 66,015 |
| 2021-02-18 | Altier Thomas (Chief Financial Officer) | Sale | 76,272 | 72.55 | 5,533,762 |
| 2021-02-18 | Cahill Edward L (Director) | Sale | 10,000 | 72.63 | 726,270 |
| 2021-01-29 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 21,829 | 66.28 | 1,446,891 |
| 2021-01-29 | Vanduyn Amy Beth (SVP, Human Resources) | Option Ex | 18,204 | .84 | 15,291 |
| 2021-01-22 | Altier Thomas (Chief Financial Officer) | Sale | 1,495 | 69.70 | 104,202 |
| 2021-01-20 | Indig Chaim (Chief Executive Officer) | Sale | 14,892 | 65.83 | 980,340 |
| 2021-01-20 | Indig Chaim (Chief Executive Officer) | Option Ex | 14,892 | 4.71 | 70,141 |
| 2021-01-20 | Linetsky David (SVP, Life Sciences) | Sale | 6,826 | 65.50 | 447,109 |
| 2021-01-19 | Altier Thomas (Chief Financial Officer) | Sale | 4,704 | 64.00 | 301,074 |
| 2021-01-19 | Weintraub Michael (Director) | Sale | 35,000 | 63.86 | 2,235,240 |
| 2021-01-19 | Weintraub Michael (Director) | Option Ex | 35,000 | 2.03 | 71,050 |
| 2021-01-19 | Indig Chaim (Chief Executive Officer) | Sale | 59,986 | 63.74 | 3,823,387 |
| 2021-01-19 | Indig Chaim (Chief Executive Officer) | Option Ex | 59,986 | 2.03 | 121,771 |
| 2021-01-19 | Linetsky David (SVP, Life Sciences) | Sale | 5,136 | 64.28 | 330,121 |
| 2021-01-19 | Roberts Evan (Chief Operating Officer) | Sale | 5,500 | 64.08 | 352,412 |
| 2021-01-15 | Indig Chaim (Chief Executive Officer) | Sale | 75,122 | 62.48 | 4,693,998 |
| 2021-01-15 | Indig Chaim (Chief Executive Officer) | Option Ex | 75,122 | 2.03 | 152,497 |
| 2021-01-05 | Roberts Evan (Chief Operating Officer) | Sale | 21,468 | 53.60 | 1,150,684 |
| 2021-01-05 | Roberts Evan (Chief Operating Officer) | Option Ex | 575 | 4.71 | 2,708 |
| 2021-01-04 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 500 | 54.26 | 27,128 |
| 2021-01-04 | Vanduyn Amy Beth (SVP, Human Resources) | Option Ex | 500 | .84 | 420 |
| 2021-01-04 | Roberts Evan (Chief Operating Officer) | Sale | 80,245 | 53.06 | 4,257,478 |
| 2021-01-04 | Smith Mark Douglas (Director) | Sale | 6,000 | 53.02 | 318,120 |
| 2021-01-04 | Smith Mark Douglas (Director) | Option Ex | 6,000 | 4.71 | 28,260 |
| 2020-12-24 | Cahill Edward L (Director) | Sale | 24,370 | 57.22 | 1,394,475 |
| 2020-12-17 | Pegus Cheryl (Director) | Sale | 8,415 | 56.15 | 472,493 |
| 2020-12-16 | Pegus Cheryl (Director) | Sale | 22,732 | 55.83 | 1,269,082 |
| 2020-12-16 | Pegus Cheryl (Director) | Option Ex | 20,764 | 11.89 | 246,883 |
| 2020-10-23 | Altier Thomas (Chief Financial Officer) | Sale | 8,669 | 38.21 | 331,207 |
| 2020-10-23 | Altier Thomas (Chief Financial Officer) | Option Ex | 8,669 | .84 | 7,281 |
| 2020-10-22 | Altier Thomas (Chief Financial Officer) | Sale | 86,237 | 37.65 | 3,246,564 |
| 2020-10-22 | Altier Thomas (Chief Financial Officer) | Option Ex | 86,237 | .84 | 72,439 |
| 2020-10-21 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 10,834 | 35.00 | 379,190 |
| 2020-10-21 | Vanduyn Amy Beth (SVP, Human Resources) | Option Ex | 9,281 | 2.03 | 18,840 |
| 2020-10-12 | Altier Thomas (Chief Financial Officer) | Sale | 6,779 | 32.13 | 217,782 |
| 2020-10-12 | Altier Thomas (Chief Financial Officer) | Option Ex | 6,779 | .00 | 0 |
| 2020-10-01 | Linetsky David (SVP, Life Sciences) | Sale | 4,477 | 31.38 | 140,488 |
| 2020-10-01 | Linetsky David (SVP, Life Sciences) | Option Ex | 1,377 | 4.71 | 6,485 |
| 2020-10-01 | Roberts Evan (Chief Operating Officer) | Sale | 14,774 | 30.93 | 456,959 |
| 2020-09-11 | Altier Thomas (Chief Financial Officer) | Sale | 6,779 | 28.29 | 191,784 |
| 2020-09-11 | Altier Thomas (Chief Financial Officer) | Option Ex | 6,779 | .84 | 5,694 |
| 2020-08-17 | Kallenbach Charles (General Counsel & Secretary) | Sale | 2,500 | 29.84 | 74,592 |
| 2020-08-17 | Kallenbach Charles (General Counsel & Secretary) | Option Ex | 2,500 | 2.55 | 6,375 |
| 2020-08-11 | Altier Thomas (Chief Financial Officer) | Sale | 6,779 | 30.40 | 206,081 |
| 2020-08-11 | Altier Thomas (Chief Financial Officer) | Option Ex | 6,779 | .84 | 5,694 |
| 2020-08-10 | Smith Mark Douglas (Director) | Sale | 6,000 | 30.30 | 181,824 |
| 2020-08-10 | Smith Mark Douglas (Director) | Option Ex | 6,000 | 4.71 | 28,260 |
| 2020-07-31 | Nathan Daniel (Chief Technology Officer) | Sale | 8,804 | 30.03 | 264,392 |
| 2020-07-31 | Nathan Daniel (Chief Technology Officer) | Option Ex | 7,000 | .69 | 4,830 |
| 2020-07-21 | Cahill Edward L (Director) | Sale | 9,080 | 29.02 | 263,519 |
| 2020-07-17 | Nathan Daniel (Chief Technology Officer) | Sale | 38,683 | 29.25 | 1,131,439 |
| 2020-07-17 | Nathan Daniel (Chief Technology Officer) | Option Ex | 38,683 | .84 | 32,493 |
| 2020-07-17 | Kallenbach Charles (General Counsel & Secretary) | Sale | 2,500 | 29.29 | 73,232 |
| 2020-07-17 | Kallenbach Charles (General Counsel & Secretary) | Option Ex | 2,500 | 2.55 | 6,375 |
| 2020-07-01 | Linetsky David (SVP, Life Sciences) | Sale | 4,475 | 28.25 | 126,396 |
| 2020-07-01 | Linetsky David (SVP, Life Sciences) | Option Ex | 1,376 | 4.71 | 6,480 |
| 2020-07-01 | Roberts Evan (Chief Operating Officer) | Sale | 12,500 | 28.45 | 355,625 |
| 2020-06-17 | Kallenbach Charles (General Counsel & Secretary) | Sale | 2,500 | 29.26 | 73,145 |
| 2020-06-17 | Kallenbach Charles (General Counsel & Secretary) | Option Ex | 2,500 | 2.55 | 6,375 |
| 2020-06-12 | Munson Gillian (Director) | Sale | 5,000 | 28.32 | 141,600 |
| 2020-06-11 | Davidoff Michael J. (See Remarks) | Option Ex | 13,084 | .84 | 10,990 |
| 2020-05-18 | Kallenbach Charles (General Counsel & Secretary) | Sale | 2,500 | 27.20 | 68,000 |
| 2020-05-18 | Kallenbach Charles (General Counsel & Secretary) | Option Ex | 2,500 | 2.55 | 6,375 |
| 2020-05-07 | Linetsky David (SVP, Life Sciences) | Sale | 255 | 26.00 | 6,630 |
| 2020-05-01 | Altier Thomas (Chief Financial Officer) | Sale | 1,096 | 24.34 | 26,673 |
| 2020-05-01 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 13,474 | 24.81 | 334,343 |
| 2020-05-01 | Vanduyn Amy Beth (SVP, Human Resources) | Option Ex | 13,474 | 2.03 | 27,352 |
| 2020-04-27 | Linetsky David (SVP, Life Sciences) | Sale | 4,220 | 26.00 | 109,720 |
| 2020-04-27 | Linetsky David (SVP, Life Sciences) | Option Ex | 1,376 | 4.71 | 6,480 |
| 2020-04-23 | Kallenbach Charles (General Counsel & Secretary) | Sale | 5,000 | 25.00 | 125,000 |
| 2020-04-23 | Kallenbach Charles (General Counsel & Secretary) | Option Ex | 5,000 | 2.55 | 12,750 |
| 2020-04-09 | Davidoff Michael J. (See Remarks) | Sale | 4,285 | 20.10 | 86,141 |
| 2020-04-01 | Davidoff Michael J. (See Remarks) | Sale | 1,404 | 20.13 | 28,263 |
| 2020-03-30 | Davidoff Michael J. (See Remarks) | Sale | 689 | 20.00 | 13,780 |
| 2020-03-27 | Davidoff Michael J. (See Remarks) | Option Ex | 31,856 | .77 | 24,369 |
| 2020-03-26 | Davidoff Michael J. (See Remarks) | Sale | 3,851 | 20.06 | 77,262 |
| 2020-03-23 | Davidoff Michael J. (See Remarks) | Sale | 700 | 20.06 | 14,044 |
| 2020-03-13 | Vanduyn Amy Beth (SVP, Human Resources) | Option Ex | 6,826 | .69 | 4,709 |
| 2020-03-13 | Linetsky David (SVP, Life Sciences) | Option Ex | 50,060 | .78 | 39,196 |
| 2020-03-13 | Roberts Evan (Chief Operating Officer) | Option Ex | 25,000 | .84 | 21,000 |
| 2020-03-12 | Indig Chaim (Chief Executive Officer) | Option Ex | 100,000 | .84 | 84,000 |
| 2020-03-02 | Davidoff Michael J. (See Remarks) | Sale | 17,066 | 30.27 | 516,621 |
| 2020-03-02 | Davidoff Michael J. (See Remarks) | Option Ex | 17,066 | 4.71 | 80,380 |
| 2020-02-21 | Linetsky David (SVP, Life Sciences) | Option Ex | 3,413 | .73 | 2,491 |
| 2020-02-19 | Nathan Daniel (Chief Technology Officer) | Sale | 9,142 | 33.70 | 308,103 |
| 2020-02-19 | Kallenbach Charles (General Counsel & Secretary) | Sale | 50 | 32.85 | 1,642 |
| 2020-02-19 | Kallenbach Charles (General Counsel & Secretary) | Option Ex | 50 | 2.55 | 127 |
| 2020-02-18 | Nathan Daniel (Chief Technology Officer) | Sale | 9,061 | 32.82 | 297,400 |
| 2020-02-18 | Nathan Daniel (Chief Technology Officer) | Option Ex | 6,826 | .73 | 4,982 |
| 2020-02-18 | Linetsky David (SVP, Life Sciences) | Sale | 3,188 | 32.88 | 104,834 |
| 2020-02-18 | Kallenbach Charles (General Counsel & Secretary) | Sale | 2,450 | 32.82 | 80,413 |
| 2020-02-18 | Kallenbach Charles (General Counsel & Secretary) | Option Ex | 2,450 | 2.55 | 6,247 |
| 2020-02-14 | Altier Thomas (Chief Financial Officer) | Option Ex | 45,510 | .00 | 0 |
| 2020-02-11 | Weintraub Michael (Director) | Sale | 9,143 | 33.02 | 301,929 |
| 2020-02-11 | Weintraub Michael (Director) | Option Ex | 9,143 | 2.03 | 18,560 |
| 2020-02-10 | Altier Thomas (Chief Financial Officer) | Sale | 10,955 | 32.85 | 359,871 |
| 2020-02-10 | Altier Thomas (Chief Financial Officer) | Option Ex | 266 | 2.03 | 539 |
| 2020-02-10 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 6,826 | 32.84 | 224,172 |
| 2020-02-10 | Vanduyn Amy Beth (SVP, Human Resources) | Option Ex | 6,826 | .73 | 4,982 |
| 2020-02-10 | Weintraub Michael (Director) | Sale | 15,177 | 32.79 | 497,623 |
| 2020-02-10 | Weintraub Michael (Director) | Option Ex | 15,177 | 2.03 | 30,809 |
| 2020-02-06 | Davidoff Michael J. (See Remarks) | Sale | 4,550 | 33.53 | 152,570 |
| 2020-02-06 | Indig Chaim (Chief Executive Officer) | Sale | 80,000 | 33.11 | 2,648,960 |
| 2020-02-06 | Indig Chaim (Chief Executive Officer) | Option Ex | 80,000 | 2.03 | 162,399 |
| 2020-02-04 | Indig Chaim (Chief Executive Officer) | Sale | 60,737 | 31.44 | 1,909,692 |
| 2020-02-04 | Indig Chaim (Chief Executive Officer) | Option Ex | 44,047 | 2.03 | 89,415 |
| 2020-02-03 | Davidoff Michael J. (See Remarks) | Sale | 11,377 | 31.06 | 353,380 |
| 2020-02-03 | Davidoff Michael J. (See Remarks) | Option Ex | 11,377 | 2.03 | 23,095 |
| 2020-02-03 | Indig Chaim (Chief Executive Officer) | Sale | 55,953 | 31.03 | 1,735,997 |
| 2020-02-03 | Indig Chaim (Chief Executive Officer) | Option Ex | 55,953 | 2.03 | 113,584 |
| 2020-01-27 | Roberts Evan (Chief Operating Officer) | Sale | 69,448 | 29.18 | 2,026,145 |
| 2020-01-13 | Davidoff Michael J. (See Remarks) | Option Ex | 21,210 | 1.19 | 25,303 |
| 2019-12-30 | Linetsky David (See Remarks) | Option Ex | 3,413 | .73 | 2,491 |
| 2019-12-24 | Davidoff Michael J. (See Remarks) | Option Ex | 1,545 | .73 | 1,127 |
| 2019-12-17 | Llr Capital Iv, L.p. (10% Owner) | Sale | 2,000,000 | 24.48 | 48,958,000 |
| 2019-12-17 | Perricelli Scott (Director) | Sale | 2,000,000 | 24.48 | 48,958,000 |
| 2019-12-17 | Pegus Cheryl (Director) | Sale | 500,000 | 24.48 | 12,239,500 |
| 2019-12-17 | Grua Peter J (10% Owner) | Sale | 2,181,577 | 24.48 | 53,402,823 |
| 2019-12-17 | Mcguire Terrance (10% Owner) | Sale | 357,121 | 24.48 | 8,741,964 |
| 2019-12-17 | Cahill Edward L (Director) | Sale | 2,181,577 | 24.48 | 53,402,823 |
| 2019-12-11 | Altier Thomas (Chief Financial Officer) | Option Ex | 41,666 | .84 | 34,999 |
| 2019-12-11 | Indig Chaim (Chief Executive Officer) | Option Ex | 3,800 | .84 | 3,192 |
| 2019-12-11 | Roberts Evan (Chief Operating Officer) | Option Ex | 3,800 | .84 | 3,192 |
| 2019-07-22 | Llr Capital Iv, L.p. (10% Owner) | Sale | 743,388 | 18.00 | 13,380,984 |
| 2019-07-22 | Perricelli Scott (Director) | Sale | 743,388 | 18.00 | 13,380,984 |
| 2019-07-22 | Ascension Health Ventures Ii, Llc (10% Owner) | Sale | 335,767 | 18.00 | 6,043,806 |
| 2019-07-22 | Pegus Cheryl (Director) | Sale | 280,689 | 18.00 | 5,052,402 |
| 2019-07-22 | Grua Peter J (10% Owner) | Sale | 540,229 | 18.00 | 9,724,122 |
| 2019-07-22 | Mcguire Terrance (10% Owner) | Sale | 396,799 | 18.00 | 7,142,382 |
| 2019-07-22 | Cahill Edward L (Director) | Sale | 540,229 | 18.00 | 9,724,122 |
Insider trading activities including stock purchases, stock sales, and option exercises of PHR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Phreesia, Inc. (symbol PHR, CIK number 1412408) see the Securities and Exchange Commission (SEC) website.